BACKGROUND. The value of routine measurements of glycosylated hemoglobin (hemoglobin A1c) in the care of patients with diabetes mellitus is uncertain. We undertook this study to determine whether knowledge of hemoglobin A1c values would result in improved metabolic control in a group of patients with insulin-dependent diabetes mellitus (IDDM). METHODS. We randomly assigned 240 patients with IDDM to one of two groups that were comparable in age, sex, duration of diabetes, and initial hemoglobin A1c levels. The patients were followed for a year, and the hemoglobin A1c concentration was measured at three-month intervals. The hemoglobin A1c values were used in assessing glycemic control and modifying therapy in one of the two groups. In the other, care givers were not aware of the hemoglobin A1c levels and relied on blood or urine glucose measurements to monitor treatment. RESULTS. Among the 222 patients still being followed after one year, the mean hemoglobin A1c value decreased significantly--from 10.1 to 9.5 percent (P less than 0.005)--in the group whose hemoglobin A1c level was monitored (n = 115), whereas the initial and one-year values in the control group (n = 107) were 10.0 and 10.1 percent, respectively. The proportion of patients with poor control, defined as those having a hemoglobin A1c value above 10.0 percent, decreased from 46 to 30 percent (P less than 0.01) in the group whose hemoglobin A1c level was monitored but did not change significantly (45 to 50 percent) in the control group. The patients in the group whose hemoglobin A1c level was monitored were seen and their insulin regimens changed more often, but they were hospitalized for acute care of their diabetes less often than those in the control group. A similar decrease in hemoglobin A1c values occurred in the control group in the following year, when their care givers knew their hemoglobin A1c values. CONCLUSIONS. Regular measurements of hemoglobin A1c lead to changes in diabetes treatment and improvement of metabolic control, indicated by a lowering of hemoglobin A1c values.
Source Information
Department of Clinical Chemistry, Odense University Hospital, Denmark.
This article has been cited by other articles:
Samuelson, L. L., Gerber, D. A.
(2009). Recent Developments in Less Invasive Technology to Monitor Blood Glucose Levels in Patients with Diabetes. Lab Med
40: 607-610
[Abstract][Full Text]
Ngaage, D. L., Jamali, A. A., Griffin, S., Guvendik, L., Cowen, M. E., Cale, A. R.
(2009). Non-infective morbidity in diabetic patients undergoing coronary and heart valve surgery. Eur. J. Cardiothorac. Surg.
35: 255-259
[Abstract][Full Text]
Sprague, R. S., Stephenson, A. H., Bowles, E. A., Stumpf, M. S., Lonigro, A. J.
(2006). Reduced Expression of Gi in Erythrocytes of Humans With Type 2 Diabetes Is Associated With Impairment of Both cAMP Generation and ATP Release. Diabetes
55: 3588-3593
[Abstract][Full Text]
Saudek, C. D., Derr, R. L., Kalyani, R. R.
(2006). Assessing Glycemia in Diabetes Using Self-monitoring Blood Glucose and Hemoglobin A1c. JAMA
295: 1688-1697
[Abstract][Full Text]
Delamater, A. M.
(2006). Clinical Use of Hemoglobin A1c to Improve Diabetes Management. Clin. Diabetes
24: 6-8
[Full Text]
Goldstein, D. E., Little, R. R., Lorenz, R. A., Malone, J. I., Nathan, D., Peterson, C. M., Sacks, D. B.
(2004). Tests of Glycemia in Diabetes. Diabetes Care
27: 1761-1773
[Full Text]
Mellinger, D. C.
(2003). Preparing Students With Diabetes for Life at College. Diabetes Care
26: 2675-2678
[Full Text]
Setter, S. M., Corbett, C. F., Campbell, R K, Cook, D., Gates, B. J.
(2003). A Survey of the Perceptions, Knowledge, and Use of A1C Values by Home Care Patients and Nurses. The Diabetes Educator
29: 144-152
[Abstract]
Sacks, D. B., Bruns, D. E., Goldstein, D. E., Maclaren, N. K., McDonald, J. M., Parrott, M.
(2002). Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Clin. Chem.
48: 436-472
[Abstract][Full Text]
Levetan, C. S., Dawn, K. R., Robbins, D. C., Ratner, R. E.
(2002). Impact of Computer-Generated Personalized Goals on HbA1c. Diabetes Care
25: 2-8
[Abstract][Full Text]
Krishnamurti, U., Steffes, M. W.
(2001). Glycohemoglobin: A Primary Predictor of the Development or Reversal of Complications of Diabetes Mellitus. Clin. Chem.
47: 1157-1165
[Abstract][Full Text]
Skeie, S., Thue, G., Sandberg, S.
(2001). Interpretation of Hemoglobin A1c (HbA1c) Values among Diabetic Patients: Implications for Quality Specifications for HbA1c. Clin. Chem.
47: 1212-1217
[Abstract][Full Text]
Dalewitz, J., Khan, N., Hershey, C. O.
(2000). Barriers to Control of Blood Glucose in Diabetes Mellitus. American Journal of Medical Quality
15: 16-25
[Abstract]
Butler, C., Peters, J., Stott, N.
(1995). Glycated haemoglobin and metabolic control of diabetes mellitus: external versus locally established clinical targets for primary care. BMJ
310: 784-788
[Abstract][Full Text]
McKelvey, J., Waller, D. A., North, A. J., Marks, J. F., Schreiner, B., Travis, L. B., Murphy, Jayn.
(1993). Reliability and Validity of the Diabetes Family Behavior Scale (DFBS). The Diabetes Educator
19: 125-132
Manske, C. L., Wilson, R. F., Wang, Y., Thomas, W.
(1992). Prevalence of, and Risk Factors for, Angiographically Determined Coronary Artery Disease in Type I-Diabetic Patients With Nephropathy. Arch Intern Med
152: 2450-2455
[Abstract]
Evidence-Based Medicine Working Group, , Guyatt, G., Cairns, J., Churchill, D., Cook, D., Haynes, B., Hirsh, J., Irvine, J., Levine, M., Levine, M., Nishikawa, J., Sackett, D., Brill-Edwards, P., Gerstein, H., Gibson, J., Jaeschke, R., Kerigan, A., Neville, A., Panju, A., Detsky, A., Enkin, M., Frid, P., Gerrity, M., Laupacis, A., Lawrence, V., Menard, J., Moyer, V., Mulrow, C., Links, P., Oxman, A., Sinclair, J., Tugwell, P.
(1992). Evidence-Based Medicine: A New Approach to Teaching the Practice of Medicine. JAMA
268: 2420-2425
[Abstract]
Makita, Z, Vlassara, H, Rayfield, E, Cartwright, K, Friedman, E, Rodby, R, Cerami, A, Bucala, R
(1992). Hemoglobin-AGE: a circulating marker of advanced glycosylation. Science
258: 651-653
[Abstract]
Retchin, S. M., Preston, J.
(1991). Effects of Cost Containment on the Care of Elderly Diabetics. Arch Intern Med
151: 2244-2248
[Abstract]
Previous
